Skip to main content
Watch Insiders

Corporate insider profile

Eric L. Keller Insider Trades

Latest reported as CHIEF EXECUTIVE OFFICER of Retension Pharmaceuticals, Inc. (RTSN).

Purchase filings
1
Reported companies
1
Net open-market value
$249,600
Latest transaction
Oct 13, 2026

Affiliated corporations

Reported company relationships

RTSNLatest reported

Retension Pharmaceuticals, Inc.

CHIEF EXECUTIVE OFFICER

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 13, 2026Retension Pharmaceuticals, Inc. (RTSN)CHIEF EXECUTIVE OFFICEROpen Market Purchase20,800$12.00$249,600